Modulation of T-regulatory cells by small molecules: potential therapy for GvHD
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is often curative for patients suffering from blood cancers. Nonetheless, significant morbidity and mortality are still prevalent. One major complication is graft versus host disease (GvHD) which occurs in 30-70% of patients. In this dis...
Prif Awdur: | Leuschner, U |
---|---|
Awduron Eraill: | Roberts, D |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
2021
|
Eitemau Tebyg
-
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
gan: Mauro Di Ianni, et al.
Cyhoeddwyd: (2024-01-01) -
The Role of Bacteria and Pattern Recognition Receptors in GvHD
gan: E. Holler, et al.
Cyhoeddwyd: (2010-01-01) -
Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells
gan: Haroon Shaikh, et al.
Cyhoeddwyd: (2022-11-01) -
Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
gan: Martin eSzyska, et al.
Cyhoeddwyd: (2016-03-01) -
Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
gan: Kudakwashe Mhandire, et al.
Cyhoeddwyd: (2021-10-01)